Tibet Aim Pharm Inc - Asset Resilience Ratio

Latest as of March 2026: 18.13%

Tibet Aim Pharm Inc (002826) has an Asset Resilience Ratio of 18.13% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tibet Aim Pharm Inc (002826) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥200.00 Million

≈ $29.27 Million USD Cash + Short-term Investments

Total Assets

CN¥1.10 Billion

≈ $161.45 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2023)

This chart shows how Tibet Aim Pharm Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Tibet Aim Pharm Inc assets under control.

Liquid Assets Composition Over Time

This chart breaks down Tibet Aim Pharm Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Tibet Aim Pharm Inc (002826) investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥200.00 Million	18.13%
Total Liquid Assets	CN¥200.00 Million	18.13%

Asset Resilience Insights

Good Liquidity Position: Tibet Aim Pharm Inc maintains a healthy 18.13% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Tibet Aim Pharm Inc Industry Peers by Asset Resilience Ratio

Compare Tibet Aim Pharm Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Tibet Aim Pharm Inc (2014–2023)

The table below shows the annual Asset Resilience Ratio data for Tibet Aim Pharm Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CN¥-2.00 ≈ $-0.29	CN¥927.74 Million ≈ $135.76 Million	-3.59pp
2019-12-31	3.59%	CN¥30.00 Million ≈ $4.39 Million	CN¥835.41 Million ≈ $122.25 Million	+3.73pp
2015-12-31	-0.14%	CN¥-570.74K ≈ $-83.52K	CN¥397.70 Million ≈ $58.20 Million	-0.96pp
2014-12-31	0.82%	CN¥2.20 Million ≈ $321.93K	CN¥268.42 Million ≈ $39.28 Million	--

pp = percentage points

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$475.17 Million

CN¥3.25 Billion CNY

Market Cap Rank

#12630 Global

#3708 in China

Share Price

CN¥17.03

Change (1 day)

+0.12%

52-Week Range

CN¥15.01 - CN¥22.24

All Time High

CN¥32.76